2018
DOI: 10.3390/md16120466
|View full text |Cite
|
Sign up to set email alerts
|

Cytotoxic Potential of the Novel Horseshoe Crab Peptide Polyphemusin III

Abstract: Biological activity of the new antimicrobial peptide polyphemusin III from the horseshoe crab Limulus polyphemus was examined against bacterial strains and human cancer, transformed, and normal cell cultures. Polyphemusin III has the amino acid sequence RRGCFRVCYRGFCFQRCR and is homologous to other β-hairpin peptides from the horseshoe crab. Antimicrobial activity of the peptide was evaluated and MIC (minimal inhibitory concentration) values were determined. IC50 (half-maximal inhibitory concentration) values … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
14
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(17 citation statements)
references
References 51 publications
3
14
0
Order By: Relevance
“…The C-amidated peptides TI–TIII lysed 66%, 56% and 41% of RBCs at 64 µM respectively (Figure 2b and Table 2). A similar trend but lower hemolytic activity had been reported for TI, TII, and TIII lacking C-terminal amidation at higher peptide concentrations [47], which is known to impact peptide activity [48,49].…”
Section: Resultssupporting
confidence: 74%
“…The C-amidated peptides TI–TIII lysed 66%, 56% and 41% of RBCs at 64 µM respectively (Figure 2b and Table 2). A similar trend but lower hemolytic activity had been reported for TI, TII, and TIII lacking C-terminal amidation at higher peptide concentrations [47], which is known to impact peptide activity [48,49].…”
Section: Resultssupporting
confidence: 74%
“…Tachyplesin I from horseshoe crabs shows an antitumor activity; however, the action mode of tachyplesin I in tumor cells remains unclear (Li et al, 2017). The new antimicrobial peptide polyphemusin III can induce cell death by destroying the plasma membrane (Marggraf et al, 2018). Purified recombinant Factor C may be applied to inhibit inflammation and septic shock (Li et al, 2007).…”
Section: Hot Research Orientationmentioning
confidence: 99%
“…Although hydrophobicity and cationicity of the peptides are essential for their activity, beyond a limit these parameters do not improve antimicrobial activity 13,[15][16][17][18][19][20][21][22] . Highly hydrophobic peptides target neutrally charged mammalian cell membrane leading to a reduction in the selectivity of target 18,[23][24][25][26] . One of the major limitations in developing AMP as a therapeutic is peptide-mediated hemolysis or cytotoxicity against host cells 27 .…”
Section: Introductionmentioning
confidence: 99%